Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes ; volume:9 ; number:1 ; day:29 ; month:10 ; year:2018 ; pages:1-9 ; date:12.2018
Nature Communications ; 9, Heft 1 (29.10.2018), 1-9, 12.2018
- Urheber
-
Veiga, Nuphar
- Beteiligte Personen und Organisationen
-
Goldsmith, Meir
Granot, Yasmin
Rosenblum, Daniel
Dammes, Niels
Kedmi, Ranit
Ramishetti, Srinivas
Peer, Dan
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-06936-1
- URN
-
urn:nbn:de:101:1-2018113012332942058645
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Veiga, Nuphar
- Goldsmith, Meir
- Granot, Yasmin
- Rosenblum, Daniel
- Dammes, Niels
- Kedmi, Ranit
- Ramishetti, Srinivas
- Peer, Dan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lipid-based delivery system for chemically modified mRNA
TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis
Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
Ionizable Lipid Nanoparticles for mRNA Delivery
Chemically modified mRNA Therapeutics for Bone Regeneration
mRNA delivery enabled by metal–organic nanoparticles
Inhalable Dry Powders for Lung mRNA Delivery
Next generation lipid nanoparticles for mRNA delivery
Translation of angiotensin converting enzyme 2 (ACE2) upon liver and lung targeted delivery of optimized chemically modified mRNA
Polymer‐Based mRNA Delivery Strategies for Advanced Therapies
Exosome for mRNA delivery: strategies and therapeutic applications
Delivery of mRNA to platelets using lipid nanoparticles
Lipid-based delivery system for chemically modified mRNA
TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis
Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
Ionizable Lipid Nanoparticles for mRNA Delivery
Chemically modified mRNA Therapeutics for Bone Regeneration
mRNA delivery enabled by metal–organic nanoparticles
Inhalable Dry Powders for Lung mRNA Delivery
Next generation lipid nanoparticles for mRNA delivery
Translation of angiotensin converting enzyme 2 (ACE2) upon liver and lung targeted delivery of optimized chemically modified mRNA
Polymer‐Based mRNA Delivery Strategies for Advanced Therapies
Exosome for mRNA delivery: strategies and therapeutic applications
Delivery of mRNA to platelets using lipid nanoparticles
Lipid-based delivery system for chemically modified mRNA
TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis
Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
Ionizable Lipid Nanoparticles for mRNA Delivery
Chemically modified mRNA Therapeutics for Bone Regeneration
mRNA delivery enabled by metal–organic nanoparticles
Inhalable Dry Powders for Lung mRNA Delivery
Next generation lipid nanoparticles for mRNA delivery
Translation of angiotensin converting enzyme 2 (ACE2) upon liver and lung targeted delivery of optimized chemically modified mRNA
Polymer‐Based mRNA Delivery Strategies for Advanced Therapies
Exosome for mRNA delivery: strategies and therapeutic applications